AR and cancer: Cancer cells can restore AR signaling through various mechanisms, including intracrine androgen synthesis, AR overexpression and amplification, point mutations, acquisition of constitutively active AR splice variants, and dysregulation of AR coactivators/corepressors that sensitize AR in response to ligand binding [27].